{
    "nct_id": "NCT05324098",
    "official_title": "Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy",
    "inclusion_criteria": "* Age >18 years\n* Ability to understand study procedures and to comply with them for the entire length of the study\n* Ability of individual or legal guardian/representative to understand an informed consent document and the willingness to sign it\n* Adenocarcinoma of the prostate\n* Current or planned anti-androgen therapy (ADT) (oral or injection) with gonadotropin-releasing hormone (GnRH) antagonist or luteinizing hormone releasing hormone (LHRH) agonist\n* Life expectancy duration of 6 months or longer from date of study consent\n* Prior and concurrent radiation is allowed\n* Treatment with concurrent androgen signaling inhibitors is allowed\n* < 75 minutes/week of vigorous aerobic exercise based on Godin survey or < 2 days per week of vigorous activity\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Contraindication to any study-related procedure or assessment\n* Planned surgery/chemotherapy/immunotherapy/parp inhibitor treatment during the study period\n* Prior and concurrent investigational therapies\n* Unable to read/speak English\n* Unable to access the Internet\n* Has seen an exercise counselor in the past 6 months for prostate or cardiovascular health\n* Has seen a dietary counselor in the past 6 months for prostate or cardiovascular health",
    "miscellaneous_criteria": ""
}